Reassessing Imaging Surveillance in Diffuse Large B-Cell Lymphoma

Dr. Brian Link discusses clinical implications of the large Mayo Clinic/ University of Iowa study (ASCO abstract 8504) showing patient symptoms rather than scheduled surveillance imaging drove detection of relapses in patients with diffuse large B-cell lymphoma (DLBCL).
Source: Cancer Network - Category: Cancer & Oncology Source Type: news